SciDEX — diseases

Understanding Entity Pages

This page aggregates everything SciDEX knows about diseases: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Wiki Pages (9)

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (2)

Source	Relation	Type	Str
AUTOPHAGY	mediates	process	0.70
NUCLEOLIN	implicated_in	protein	0.70

Targeting Hypotheses (1)

Hypothesis	Score	Disease	Analysis
Tissue-specific interactome destabilization drives phenotype	0.000	Mendelian neurological diseases (neurodegeneration)	What molecular mechanisms drive tissue-s

Hypothesis

Score

Disease

Analysis

Tissue-specific interactome destabilization drives phenotype

0.000

Mendelian neurological diseases (neurodegeneration)

What molecular mechanisms drive tissue-s

Mentioning Analyses (24)

Experiments (0)

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Experiment

Type

Disease

Score

Feasibility

Model

Status

Est. Cost

No experiments found

Title & PMID	Authors	Journal	Year	Citations
No papers found

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

closed · Rounds: 4 · Score: 0.77 · 2026-04-25

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

closed · Rounds: 4 · Score: 0.79 · 2026-04-21

The abstract mentions multiple organelles synchronously present structural deran

closed · Rounds: 4 · Score: 0.80 · 2026-04-21

TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leadi

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

The review covers various organelle-specific autophagy types but doesn't address

closed · Rounds: 4 · Score: 0.66 · 2026-04-21

Related Research

Hypotheses and analyses mentioning diseases in their description or question text

diseases

Understanding Entity Pages

Wiki Pages (9)

Diseases

Caregiver Support and Palliative Care in Atypical [Parkinson's disease](/diseases/parkinsons-disease)ism

Senolytic Therapies for CBS and [PSP](/diseases/progressive-supranuclear-palsy)

[AD](/diseases/alzheimers-disease) Failed Approaches Analysis

Tau Pathology Alters Oligodendrocyte Gene Methylation in [Alzheimer's Disease](/diseases/alzheimers-disease)

epidemiology-neurodegenerative-diseases

Neuroinflammation in [Parkinson's Disease](/diseases/parkinsons-disease)

[p53](/proteins/tp53) Pathway in [Parkinson](/diseases/parkinsons-disease)'s Disease

Metachromatic Leukodystrophy ([MLD](/diseases/metachromatic-[leukodystrophy](/diseases/leukodystrophy)))

Outgoing (0)

Incoming (2)

Targeting Hypotheses (1)

Mentioning Analyses (24)

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

Comparative epigenetic signatures: DNA methylation age acceleration and histone

Comparative epigenetic signatures: DNA methylation age acceleration and histone

Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron

Comparative epigenetic signatures across AD, PD, and ALS

Does LRRK2's role as a lysosomal volume sensor explain the pathogenic mechanism

What are the precise temporal dynamics of astrocyte ketone production decline du

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

Why does autophagy inhibition improve neuronal survival when autophagy is typica

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

Are autophagy-lysosome defects primary drivers or downstream consequences in spo

What determines organelle-specific autophagy selectivity in neurodegenerative di

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

How do different organelle-specific autophagy pathways coordinate during neurode

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

Senescent cell clearance as neurodegeneration therapy

CRISPR-based therapeutic approaches for neurodegenerative diseases

CRISPR-based therapeutic approaches for neurodegenerative diseases

Metabolic reprogramming in neurodegenerative disease

Protein aggregation cross-seeding across neurodegenerative diseases

Autophagy-lysosome pathway convergence across neurodegenerative diseases

Protein aggregation cross-seeding across neurodegenerative diseases

Experiments (0)

Related Papers (0)

Debates (20)

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

The abstract mentions multiple organelles synchronously present structural deran

TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leadi

The review covers various organelle-specific autophagy types but doesn't address

Related Research